SCHEMBL15918533

SCHEMBL15918533

Cc1nc2c(s1)CN(C[B-](F)(F)F)CC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAD52 P43351 1/20 0.47
RECQL P46063 1/20 0.47
PDE10A Q9Y233 1/20 0.39
GRM5 P41594 5/20 0.39
GAA P10253 3/20 0.38
DPP4 P27487 1/20 0.36
DPP8 Q6V1X1 1/20 0.36
DPP9 Q86TI2 1/20 0.36
DPP7 Q9UHL4 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
PDCD1 Q15116 2/20 0.34
CD274 Q9NZQ7 2/20 0.34
KMT2A Q03164 5/20 0.33
ALDH1A1 P00352 3/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
MAPT P10636 3/20 0.33
KDM4E B2RXH2 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL16583490 0.98 RAD52 (0.46) RAD52RECQLPDE10AGRM5GAA
SCHEMBL16609856 0.82 RAD52 (0.47) RAD52RECQLPDE10AGRM5GAA
SCHEMBL6369558 0.81 RAD52 (0.69) RAD52RECQLPDE10AGRM5GAA
SCHEMBL16609857 0.79 RAD52 (0.47) RAD52RECQLPDE10AGRM5GAA
SCHEMBL16809359 0.79 RAD52 (0.47) RAD52RECQLPDE10AGRM5GAA
SCHEMBL17088067 0.77 RAD52 (0.48) RAD52RECQLPDE10AGRM5GAA
SCHEMBL16286091 0.77 RAD52 (0.48) RAD52RECQLPDE10AGRM5GAA
SCHEMBL16286089 0.77 RAD52 (0.48) RAD52RECQLPDE10AGRM5GAA
SCHEMBL15918535 0.76 GRM5 (0.47) RAD52RECQLPDE10AGRM5DPP4
SCHEMBL21451958 0.76 RAD52 (0.47) RAD52RECQLPDE10AGRM5GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2953681-B1 NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS BOEHRINGER INGELHEIM INT (DE) 2017-03-15 EP disclosed
US-8927531-B2 Indanyloxydihydrobenzofuranylacetic acids BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-01-06 US disclosed
US-20140221349-A1 INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221349-A1 INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS GPR119, GPBAR1, GPR52 RAD52 3037/4885RECQL 4082/4885PDE10A 1360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.